Tavakoli, M. et al. 2026. Assessment of Neuroendocrine Features Using 99mTc-Octreotide Scintigraphy in Patients with Metastatic Castration-Resistant Prostate Cancer: Does it Predict Response to 177Lu-PSMA Radioligand Therapy?. Urology Journal. 23, 03 (Aug. 2026), 100–106. DOI:https://doi.org/10.22037/uj.v23i03.8610.